Achieve Life Sciences, Inc. Deferred Revenue (Non-Current)
Achieve Life Sciences, Inc. (ACHV) had Deferred Revenue (Non-Current) of $0 as of 2011-12-31, per its 10-K filed 2012-03-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2012-03-08
- 2011-12-31: Deferred Revenue, Noncurrent $0.00.
- 2011-09-30: Deferred Revenue, Noncurrent $9.04M.
- 2011-06-30: Deferred Revenue, Noncurrent $9.87M.
- 2010-12-31: Deferred Revenue, Noncurrent $11.62M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-03-08 |
| 2011-09-30 | $9.04M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $9.87M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $11.62M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |